Description

Enhanced Power and Efficiency:

The Executive Series Centrifuge II stands out for its exceptional features and benefits, setting a new standard in autologous regenerative therapies.

Below is a summarized list of its key attributes:

• The Executive Series Centrifuge II has more power, and a lighter bucket configuration;
• These enhancements improve blood and bone marrow separation in a shorter time period than its predecessor;
• The buckets are specially designed with aerosol caps that prevent blood atomization during centrifugation;
• This feature adds additional safety controls for the patient, and further sets EmCyte apart from the competition;
• Optimal performance has now come to a machine that’s elegant, lightweight, and digitally operated;
• The totally mobile machine has a smaller footprint, allowing its use in the most confined spaces;
• Operating at just above a whisper, the new Executive Series Centrifuge II is a pleasure to use in any clinical situation.

The Executive Series Centrifuge II not only advances blood and bone marrow separation techniques but also emphasizes patient safety, operational efficiency, and ease of use in clinical settings.

EmCyte Corporation, continues to move the bar of excellence in autologous regenerative therapies.